CDK4 and breast cancer: Given that the EMT-inducing transcription factor ZEB1 plays an essential role in cancer cell plasticity and tumor recurrence, future studies should focus on the role CDK4/6-USP51 signaling plays in breast cancer initiation, aggressiveness and therapy resistance through ZEB1.